Figure 1. Research Method Flow Chart 12
Figure 2. Breakdown of Primary Research 14
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 18
Figure 5. Global Digital Respiratory Solutions Market, 2019-2030, $ mn 20
Figure 6. Primary Drivers and Impact Factors of Global Digital Respiratory Solutions Market 23
Figure 7. GDP per capita in the World, 1960-2018, $ thousand 26
Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million 26
Figure 9. Worldwide Connected Devices by Device Type, 2014-2022, billion units 27
Figure 10. Primary Restraints and Impact Factors of Global Digital Respiratory Solutions Market 28
Figure 11. Investment Opportunity Analysis 32
Figure 12. Porter’s Fiver Forces Analysis of Global Digital Respiratory Solutions Market 35
Figure 13. Breakdown of Global Digital Respiratory Solutions Market by Product Type, 2019-2030, % of Sales Revenue 40
Figure 14. Global Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%) 41
Figure 15. Global Digital Respiratory Solutions Market: Therapeutic Devices, 2019-2030, $ mn 42
Figure 16. Global Digital Respiratory Solutions Market: Inhalers, 2019-2030, $ mn 43
Figure 17. Global Digital Respiratory Solutions Market: Nebulizers, 2019-2030, $ mn 44
Figure 18. Global Digital Respiratory Solutions Market: Diagnostic Devices, 2019-2030, $ mn 45
Figure 19. Global Digital Respiratory Solutions Market: Spirometers, 2019-2030, $ mn 47
Figure 20. Global Digital Respiratory Solutions Market: Asthma Monitors, 2019-2030, $ mn 48
Figure 21. Global Digital Respiratory Solutions Market: Other Diagnostic Devices, 2019-2030, $ mn 49
Figure 22. Global Digital Respiratory Solutions Market: Sensors and Apps, 2019-2030, $ mn 50
Figure 23. Breakdown of Global Digital Respiratory Solutions Market by Indication, 2019-2030, % of Sales Revenue 52
Figure 24. Global Addressable Market Cap in 2020-2030 by Indication, Value ($ mn) and Share (%) 52
Figure 25. Global Digital Respiratory Solutions Market: Asthma, 2019-2030, $ mn 53
Figure 26. Global Digital Respiratory Solutions Market: Chronic Obstructive Pulmonary Disease (COPD), 2019-2030, $ mn 54
Figure 27. Global Digital Respiratory Solutions Market: COVID-19 Caused Diseases, 2019-2030, $ mn 55
Figure 28. Global Digital Respiratory Solutions Market: Other Diseases, 2019-2030, $ mn 56
Figure 29. Breakdown of Global Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, % of Revenue 58
Figure 30. Global Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 58
Figure 31. Global Digital Respiratory Solutions Market: Hospital Pharmacies, 2019-2030, $ mn 59
Figure 32. Global Digital Respiratory Solutions Market: Retail Pharmacies, 2019-2030, $ mn 60
Figure 33. Global Digital Respiratory Solutions Market: Online Pharmacies, 2019-2030, $ mn 61
Figure 34. Global Market Snapshot by Region 62
Figure 35. Geographic Spread of Worldwide Digital Respiratory Solutions Market, 2019-2030, % of Sales Revenue 63
Figure 36. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%) 64
Figure 37. Health Spending as a Share of GDP by Country, 2015 and 2030 66
Figure 38. North American Digital Respiratory Solutions Market, 2019-2030, $ mn 69
Figure 39. Breakdown of North America Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 70
Figure 40. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 71
Figure 41. U.S. Digital Respiratory Solutions Market, 2019-2030, $ mn 73
Figure 42. Canada Digital Respiratory Solutions Market, 2019-2030, $ mn 76
Figure 43. Digital Respiratory Solutions Market in Mexico, 2015-2030, $ mn 78
Figure 44. European Digital Respiratory Solutions Market, 2019-2030, $ mn 81
Figure 45. Breakdown of European Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 82
Figure 46. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 83
Figure 47. Digital Respiratory Solutions Market in Germany, 2019-2030, $ mn 84
Figure 48. Digital Respiratory Solutions Market in UK, 2019-2030, $ mn 86
Figure 49. Digital Respiratory Solutions Market in France, 2019-2030, $ mn 88
Figure 50. Digital Respiratory Solutions Market in Spain, 2019-2030, $ mn 90
Figure 51. Digital Respiratory Solutions Market in Italy, 2019-2030, $ mn 92
Figure 52. Digital Respiratory Solutions Market in Russia, 2019-2030, $ mn 94
Figure 53. Digital Respiratory Solutions Market in Rest of Europe, 2019-2030, $ mn 96
Figure 54. Asia-Pacific Digital Respiratory Solutions Market, 2019-2030, $ mn 99
Figure 55. Breakdown of APAC Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 99
Figure 56. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 101
Figure 57. Digital Respiratory Solutions Market in Japan, 2019-2030, $ mn 103
Figure 58. Digital Respiratory Solutions Market in China, 2019-2030, $ mn 106
Figure 59. Digital Respiratory Solutions Market in Australia, 2019-2030, $ mn 108
Figure 60. Digital Respiratory Solutions Market in India, 2019-2030, $ mn 110
Figure 61. Digital Respiratory Solutions Market in South Korea, 2019-2030, $ mn 112
Figure 62. Digital Respiratory Solutions Market in Rest of APAC, 2019-2030, $ mn 114
Figure 63. South America Digital Respiratory Solutions Market, 2019-2030, $ mn 117
Figure 64. Breakdown of South America Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 117
Figure 65. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 118
Figure 66. Digital Respiratory Solutions Market in Argentina, 2019-2030, $ mn 119
Figure 67. Digital Respiratory Solutions Market in Brazil, 2019-2030, $ mn 121
Figure 68. Digital Respiratory Solutions Market in Chile, 2019-2030, $ mn 123
Figure 69. Digital Respiratory Solutions Market in Rest of South America, 2019-2030, $ mn 125
Figure 70. Digital Respiratory Solutions Market in MEA, 2019-2030, $ mn 127
Figure 71. Breakdown of MEA Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 127
Figure 72. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 128
Figure 73. Digital Respiratory Solutions Market in UAE, 2019-2030, $ mn 129
Figure 74. Digital Respiratory Solutions Market in Saudi Arabia, 2019-2030, $ mn 131
Figure 75. Digital Respiratory Solutions Market in South Africa, 2019-2030, $ mn 133
Figure 76. Growth Stage of Global Digital Respiratory Solutions Industry over the Forecast Period 136
Table 1. Snapshot of Global Digital Respiratory Solutions Market, 2019-2030 19
Table 2. Main Product Trends and Market Opportunities in Global Digital Respiratory Solutions Market 31
Table 3. Global Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 40
Table 4. Global Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 42
Table 5. Global Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 46
Table 6. Global Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 51
Table 7. Global Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 57
Table 8. Global Digital Respiratory Solutions Market by Region, 2019-2030, $ mn 63
Table 9. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 65
Table 10. Leading National Digital Respiratory Solutions Market, 2019 and 2030, $ mn 67
Table 11. North America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 70
Table 12. U.S. Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 74
Table 13. U.S. Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 74
Table 14. U.S. Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 74
Table 15. Canada Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 77
Table 16. Canada Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 77
Table 17. Canada Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 77
Table 18. Mexico Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 79
Table 19. Mexico Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 79
Table 20. Mexico Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 79
Table 21. Europe Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 83
Table 22. Germany Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 85
Table 23. Germany Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 85
Table 24. Germany Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 85
Table 25. UK Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 87
Table 26. UK Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 87
Table 27. UK Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 87
Table 28. France Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 89
Table 29. France Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 89
Table 30. France Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 89
Table 31. Spain Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 91
Table 32. Spain Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 91
Table 33. Spain Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 91
Table 34. Italy Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 93
Table 35. Italy Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 93
Table 36. Italy Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 93
Table 37. Russia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 95
Table 38. Russia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 95
Table 39. Russia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 95
Table 40. Digital Respiratory Solutions Market in Rest of Europe by Country, 2019-2030, $ mn 97
Table 41. APAC Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 100
Table 42. Japan Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 104
Table 43. Japan Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 104
Table 44. Japan Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 104
Table 45. China Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 107
Table 46. China Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 107
Table 47. China Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 107
Table 48. Australia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 109
Table 49. Australia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 109
Table 50. Australia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 109
Table 51. India Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 111
Table 52. India Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 111
Table 53. India Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 111
Table 54. South Korea Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 113
Table 55. South Korea Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 113
Table 56. South Korea Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 113
Table 57. Digital Respiratory Solutions Market in Rest of APAC by Country, 2019-2030, $ mn 115
Table 58. South America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 118
Table 59. Argentina Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 120
Table 60. Argentina Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 120
Table 61. Argentina Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 120
Table 62. Brazil Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 122
Table 63. Brazil Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 122
Table 64. Brazil Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 122
Table 65. Chile Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 124
Table 66. Chile Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 124
Table 67. Chile Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 124
Table 68. MEA Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 128
Table 69. UAE Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 130
Table 70. UAE Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 130
Table 71. UAE Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 130
Table 72. Saudi Arabia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 132
Table 73. Saudi Arabia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 132
Table 74. Saudi Arabia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 132
Table 75. South Africa Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 134
Table 76. South Africa Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 134
Table 77. South Africa Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 134
Table 78. 3M Health Care Limited: Company Snapshot 140
Table 79. 3M Health Care Limited: Business Segmentation 140
Table 80. 3M Health Care Limited: Product Portfolio 141
Table 81. 3M Health Care Limited: Revenue, 2016-2018, $ mn 141
Table 82. 3M Health Care Limited: Recent Developments 141
Table 83. Risk Evaluation for Investing in Global Market, 2019-2030 159
Table 84. Critical Success Factors and Key Takeaways 162
Safe and Secure SSl Encryption
Licensing options
3300
USD
You can select one of these options upon checking out
Allows one individual to access the purchased report
Allows up to five individuals to access the purchased report
Allows all employees of an organization to access the purchased report. Internal sharing only
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral
North America: +1 201 793 8545 Europe: +44 20 8089 0049 Asia-Pacific: +91 7878231309
Email us on:- sales@bonafideresearch.com
Order Placed (04 February, 2023)
Notify To Team (04 February, 2023)
Report updation (05 February, 2023)
Report Quality Check (05 February, 2023)
Report Dispatch (06 February, 2023)
Hard Copy
Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer $1000 worth of FREE customization at the time of purchase
80% of the clinet request tailor made solution, how can we help you?
Avail customized purchase options to meet your exact research needs:
READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.
CEO
Vivek Arora
BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!
EXECUTIVE DIRECTOR
Rahul Roy
THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.
SALES DIRECTOR
Arjun Prasad
THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH
President
Manish Verma
Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
MARKETING DIRECTOR
Gautam Saxena
The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.
PRODUCT MANAGER
Tom Stone
I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.
Associate Director
Mark Wood
Global digital respiratory solutions market will reach $319.3 million by 2030, growing by 36.2% annually over 2020-2030 driven by the rising demand for air filtration amid COVID-19 pandemic. Highlighted with 84 tables and 76 figures, this 164-page report “Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Therapeutic Devices • Inhalers • Nebulizers Diagnostic Devices • Spirometers • Asthma Monitors • Other Diagnostic Devices Sensors and Apps Based on Indication, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Asthma • Chronic Obstructive Pulmonary Disease (COPD) • COVID-19 Caused Diseases • Other Diseases Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): 3M Health Care Limited Adherium Limited Amiko Digital Health Limited AsthmaMD AstraZeneca plc Boehringer Ingelheim International GmbH Capsule Technologies, Inc. Cohero Health GlaxoSmithKline plc Kaia Health Software GmbH Medical International Research (MIR) Novartis AG NuvoAir Reciprocal Labs (Propeller Health) Sensiron AG Tactio Health Teva Pharmaceuticals Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More